Viewing Study NCT07297602

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2026-02-05 @ 3:56 AM
Study NCT ID: NCT07297602
Status: RECRUITING
Last Update Posted: 2025-12-22
First Post: 2025-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study
Sponsor: Nora Mohamed Abdelrazik
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atopic Dermatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Atopic dermatitis, Oral roflumilast, Moderate-to-severe AD, Efficacy, Safety, Adolescents and … View